• Protease Inhibitor Cocktail for Lipid Droplet Assays

  2026-08-24

  Learn how to use a broad-spectrum, EDTA-containing inhibitor formulation to preserve DFCP1–ATGL complexes and other labile proteins during lipid droplet extraction. Practical workflows cover cell lysates, tissue extracts, co-immunoprecipitation, Western blotting, fractionation, and EDTA-sensitive downstream assays.

• E. coli Uracil-DNA Glycosylase (UDG) Guide

  2026-08-24

  E. coli UDG (K1107) removes uracil from single- and double-stranded DNA, supporting PCR product contamination elimination when prior amplicons contain uracil. It is intended for research DNA workflows, not RNA, oligonucleotides shorter than six bases, or diagnostic and medical applications.

• Smoothened Agonist (SAG) Assay Guide

  2026-08-23

  A scenario-based guide to using Smoothened Agonist (SAG), SKU B5837, in viability, proliferation, cytotoxicity, and Hedgehog pathway activation assays. It covers concentration selection, solvent controls, pathway-specific interpretation, storage, and practical product evaluation.

• Sabutoclax Workflows for Apoptosis Research

  2026-08-22

  Sabutoclax enables mechanism-aware apoptosis studies by combining broad anti-apoptotic Bcl-2 family coverage with strong membrane permeability. This guide shows how to separate cytostatic effects from cell killing, optimize dose–time experiments, and extend findings from cancer cell assays to xenograft research.

• Fumagillin Workflows for Angiogenesis Research

  2026-08-22

  Fumagillin is a methionine aminopeptidase-2 inhibitor suited to mechanistic studies of endothelial cell proliferation inhibition, angiogenesis, and tumor models. This practical guide also shows how its moderate antiparasitic activity can inform assay design without confusing in vitro screening results with validated in vivo treatment.

• DAPI (hydrochloride) for DNA and Cell-Cycle Assays

  2026-08-21

  DAPI (hydrochloride) supports high-contrast nuclear imaging, chromosome staining, and DNA-content analysis in both fixed and live-cell workflows. This practical guide connects assay design, multiplexing, and troubleshooting with the cellular readouts needed to interpret immunomodulatory cancer research.

• Isoprenaline Hydrochloride in Heart–Brain Models

  2026-08-20

  Isoprenaline Hydrochloride, also known as isoproterenol, provides a controllable way to activate β1- and β2-adrenergic receptors in cardiac, vascular, airway, and heart–brain experiments. This guide translates the compound’s established use into practical workflows for ECG phenotyping, angiogenesis assays, bronchospasm research, and vagal-mediated neurocardiac studies.

• Developmental SSRI Exposure and Mu Opioid Signaling

  2026-08-20

  Cambre’s 2026 dissertation shows that developmental SSRI exposure produces persistent, motivation-specific reward deficits in adolescent and adult mice. Progressive-ratio behavior was improved by mu opioid receptor antagonism or nucleus accumbens MOR knockdown, whereas additional SSRI treatment and the MOR agonist tianeptine were ineffective.

• MTT for Cell Viability: Workflow and Troubleshooting

  2026-08-19

  Build more reproducible cell proliferation, cytotoxicity, and metabolic activity experiments with MTT, from reagent preparation through optical readout. The workflow also shows how MTT can support host-cell tolerance studies inspired by plantaricin-derived antibiotic adjuvants without confusing metabolic readouts with bacterial membrane permeability.

• Amorolfine Hydrochloride in Ploidy-Stress Assays

  2026-08-19

  Amorolfine Hydrochloride enables membrane-focused fungal assays that connect drug response with ploidy, cell size, and surface-stress biology. This workflow combines solvent-aware dosing, orthogonal membrane readouts, and strain-matched controls for fungal infection research and antifungal resistance studies.

• Cy3 RNA Labeling Kit: Reliable RNA Probes

  2026-08-18

  This scenario-driven guide explains how the HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit (SKU K1061) supports reproducible fluorescent RNA probe preparation for in situ hybridization and Northern blot workflows. It also clarifies how Cy3 probe data can complement, but not replace, cell viability, proliferation, and cytotoxicity measurements.

• Marein Reverses ABCG2-Mediated Drug Resistance

  2026-08-18

  The 2024 Biochemical Pharmacology study identifies marein, a flavonoid from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug-efflux transporter. By increasing intracellular exposure to ABCG2 substrates including Mitoxantrone, topotecan, and olaparib, marein restored drug sensitivity in resistant cancer-cell models and established a mechanistic framework for studying transporter-mediated chemotherapy failure.

• Lamotrigine at the BBB–Neurocardiac Interface

  2026-08-17

  A translational strategy for using Lamotrigine to connect sodium-channel biology, serotonin signaling, blood–brain barrier modeling, and neurocardiac risk assessment in reproducible preclinical workflows.

• SAG: Precision Hedgehog Signaling, Beyond Activation

  2026-08-17

  SAG is more than a pathway switch: it is a context-dependent Smoothened receptor agonist whose value depends on dose, developmental timing, biological state, and translational controls. New embryonic evidence shows why mechanistic precision matters.

• FPH1 (BRD-6125): Functional Hepatocyte Assays

  2026-08-16

  FPH1 (BRD-6125) is a functional proliferation enhancer for primary human hepatocyte culture and iPS-derived hepatocyte models. This article explains how to distinguish cell expansion from maturation, integrate orthogonal functional readouts, and interpret light-regulated gene-expression concepts without conflating separate experimental systems.

7969 records 1/532 page Next 12345 下5页 Last page